Anzeige
❌
Mehr »
Samstag, 17.10.2026 - Börsentäglich über 12.000 News
Der CEO hat rund eine Milliarde Dollar an Übernahmen integriert, bevor es dieses Unternehmen gab
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
MA

WKN: A40RA3 | ISIN: US56270V2051 | Ticker-Symbol:
NASDAQ
16.10.26 | 22:00
0,290 US-Dollar
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
MANGOCEUTICALS INC Chart 1 Jahr
5-Tage-Chart
MANGOCEUTICALS INC 5-Tage-Chart

Aktuelle News zur MANGOCEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
09.10.Mangoceuticals sichert sich 500.000 US-Dollar durch Direktplatzierung2
09.10.Mangoceuticals, Inc.: Mangoceuticals Closes Registered Direct Offering Priced at 74% Premium to Recent Market Close1
09.10.MANGOCEUTICALS, INC. - 8-K, Current Report2
02.10.Mangoceuticals (MGRX) Shares Fall 12% After Hours: Here's Why1
01.10.Mangoceuticals-Tochter sichert sich 2,5-Millionen-Dollar-Investment1
01.10.Mangoceuticals, Inc.: Mangoceuticals Secures $2.5 Million Strategic Investment in MangoRx IP Holdings; Receives Initial $1.75 Million Tranche169Subsidiary-Level Investment Provides Capital to Advance Commercialization of the Company's Antiviral Intellectual Property Portfolio with No Issuance of MGRX Common Stock DALLAS, TEXAS, Oct. 01, 2026...
► Artikel lesen
01.10.MANGOCEUTICALS, INC. - 8-K, Current Report1
21.08.MANGOCEUTICALS, INC. - 8-K, Current Report1
MANGOCEUTICALS Aktie jetzt für 0€ handeln
13.08.MANGOCEUTICALS, INC. - 10-Q, Quarterly Report3
06.08.Mangoceuticals (MGRX) Stock Jumps Over 49% After Hours: Here's Why1
04.08.Mangoceuticals, Inc.: Mangoceuticals Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Price Requirement and Comments on Nuclea Energy Business Combination213Dallas, Texas, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX) ("Mangoceuticals" or the "Company") today announced it has received an additional 180-calendar-day extension from...
► Artikel lesen
03.08.Nuclea Energy To Go Public Through Mangoceuticals Combination With Former Shareholders Owning About 96%2
30.07.Nuclea Energy Inc: Nuclea Energy Enters Definitive Business Combination Agreement with Mangoceuticals, Establishing a Path to a Nasdaq Public Listing to Advance the Morpheus Microreactor886Mississauga, Ontario--(Newsfile Corp. - July 30, 2026) - Nuclea Energy Inc. ("Nuclea" or the "Company"), an advanced nuclear technology company headquartered in Mississauga, Ontario, developing...
► Artikel lesen
30.07.Mangoceuticals agrees to merge with nuclear microreactor developer6
30.07.Mangoceuticals kündigt Fusion mit Nukleartechnik-Unternehmen Nuclea an4
30.07.Mangoceuticals, Inc.: Mangoceuticals Announces Business Combination Agreement with Nuclea Energy Inc. to Advance Next-Generation Nuclear Microreactor Technology6.939Business Combination Agreement to Bring Nuclea's Lead-Cooled Morpheus Microreactor to the Public Markets Amid Surging Power Demand from AI and Data Centers DALLAS, TEXAS, July 30, 2026 (GLOBE NEWSWIRE)...
► Artikel lesen
30.07.MANGOCEUTICALS, INC. - 8-K, Current Report4
10.07.MANGOCEUTICALS, INC. - S-8, Securities to be offered to employees in employee benefit plans2
02.07.MANGOCEUTICALS, INC. - 8-K, Current Report1
19.05.MANGOCEUTICALS, INC. - 10-Q, Quarterly Report2
1 2 Weiter >>
24 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1